Status:
UNKNOWN
Evaluation of the OtoBand as a Treatment to Reduce the Perceived Loudness of Tinnitus
Lead Sponsor:
Otolith Labs
Conditions:
Tinnitus
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
This proposed study is a blinded study in which the participant will wear the OtoBand when their tinnitus is present to determine if the OtoBand reduces the perceived loudness of their tinnitus. The S...
Detailed Description
This study seeks to gather data on the effect of the OtoBand in participants who have reported symptoms of tinnitus. The study is designed to be conducted remotely using video conferencing between rep...
Eligibility Criteria
Inclusion
- Male or female subjects age 18 to 70 years old
- Tinnitus that has been present for at least 90 days
- Tinnitus that is constant or predictable
- Computer and access to internet for online video conference
- Score greater than or equal to 36 on the Tinnitus Handicap Questionnaire
- Access to a PayPal, Venmo account to receive compensation
Exclusion
- Tinnitus that first presented within the last 90 days
- Tinnitus Handicap Questionnaire of 29 or less
- Skull base surgery within the last 90 days
- Any skull implant (cochlear implant, bone conduction implant, DBS)
- No history of vitreous detachment in the last 60 days (no new floaters or unexplained flashes of light in the eye)
- Taking benzodiazepines (e.g. clonazepam, lorazepam, diazepam) Participant reports that their tinnitus is caused by a medication they are taking
Key Trial Info
Start Date :
March 5 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04787653
Start Date
March 5 2021
End Date
February 28 2024
Last Update
March 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
OtolithLabs https://otolithlabs.com/tinnitustelehealthstudy/
Washington D.C., District of Columbia, United States, 20009